Global coronovirus cases exceeded 30 million on Thursday, according to a Reuters tally, showing no signs of slowing of the epidemic.
India was firmly focused as the latest epicenter, although North and South America still accounted for nearly half of global affairs.
Global new daily case numbers reached record levels in recent times and caused close to 1 million deaths as an international race to heat and develop a vaccine.
According to world health data, the official number of global coronovirus cases is now five times the number of serious influenza illnesses reported annually.
Worldwide, given the two-week incubation period of the virus, there have been approximately 1 million deaths, considered a lagging indicator. It has crossed the upper limit of 290,000 to 650,000 annual deaths associated with influenza.
India became only the second country in the world after the United States this week, registering more than 5 million cases. On Thursday, it recorded another record of a daily increase of around 98,000 cases.
The South Asian country, the world’s second most populous country, has been reporting more new daily cases than the United States since mid-August and accounts for just 16% of global known cases.
Reported deaths in India have been relatively low so far, but are showing a boom, and the country has recorded more than 1,000 deaths every day for the past two weeks.
The United States has about 20% of all global cases, although it has just 4% of the world’s population. Brazil, the third largest country, accounts for about 15% of global affairs.
It took 18 days for global cases to increase from 25 million to over 30 million. It took 20 days for the world to go from 20 million to 25 million and 19 million to 15 million to 20 million.
The global rate of new daily cases is slowing progress in increasing the disease in many countries, despite some big upsides.
Australia on Thursday reported its lowest single-day case increase since June, as strict lockdown measures in its country’s second-largest city, Melbourne, appeared to pay off the country’s second wave.
Health experts believe that official data almost certainly underline both infections and deaths, especially in countries with limited testing capacity.
The race to develop and market a novel coronovirus vaccine has become increasingly frenzied in recent weeks with the development of around 200 candidates globally.
US President Donald Trump has said that his country may have a vaccine ready for distribution ahead of the US election on November 3, while a Chinese health official said this week that a vaccine could be ready in China that went public in early November Be for use.
While the trajectory of coronovirus is still significantly lower than the Spanish flu of 1918, which infects an estimated 500 million people, killing at least 10% of them, experts believe that the available data are the true epidemic Reducing the effect.
(This story has not been edited by NDTV staff and auto-generated from a syndicated feed.)